Atlas Trials

Dose-finding Study of GSK2248761 in Antiretroviral Therapy-experienced Subjects With NNRTI-resistant HIV Infection

Clinical trial NCT01199731 · TERMINATED

Trial details

NCT number
NCT01199731
Sponsor
ViiV Healthcare
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Infection, Human Immunodeficiency Virus
Start date
2010-10-05
Primary completion
2011-07-19
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.